BridgeMD
New treatment option for Diabetes Mellitus, Type 2
Official title Phenotypic and Genotypic Characterization of Patients With Dysmetabolism in Greenland
ClinicalTrials.gov ID: NCT06264427
What this study is testing
What is Whole genome sequencing?
Whole genome sequencing is an investigational medicine, being studied as a potential treatment for diabetes mellitus, type 2.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The study aims to learn about the genetic and physical traits of people with type 2 diabetes and severe obesity. It also wants to see if personalized medicine can improve treatment and how common sleep apnea is in this group.
- Who it's for
- The study is looking for people living in Greenland who have type 2 diabetes and severe obesity.
- What's involved
- Participants will answer questionnaires about their quality of life, undergo physical exams, and provide blood samples for genetic testing.
- Time commitment
- The study duration and number of visits are not specified.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older
You may be able to join if
- Type 2 diabetes and/or morbid obesity (BMI \>40)
- Over 18 years old
You likely can't join if
- Does not speak either English, Danish or Greenlandic
The study team makes the final eligibility decision.
Where it's taking place
- Nuuk, Sermersooq, Greenland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Nuuk, Sermersooq, Greenland. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.